Safety, tolerability and efficacy of up-titration of guideline-directed medical therapies for acute heart failure (STRONG-HF): a multinational, open-label, randomised, trialAlexandre Mebazaa, Gad Cotter, Beth A. Davison et al.|The Lancet|2022Cited by 1k
Recognition and Initial Management of Fulminant MyocarditisRobb D. Kociol, Orly Vardeny, Leslie T. Cooper et al.|Circulation|2020Cited by 593
Persistent pulmonary congestion before discharge predicts rehospitalization in heart failure: a lung ultrasound studyLuna Gargani, Eugenio Picano, Patrizia Landi et al.|Cardiovascular Ultrasound|2015Cited by 236
The impact of early standard therapy on dyspnoea in patients with acute heart failure: the URGENT-dyspnoea studyAlexandre Mebazaa, Mihai Gheorghiade, Peter S. Pang et al.|European Heart Journal|2009Cited by 188
A proposal to standardize dyspnoea measurement in clinical trials of acute heart failure syndromes: the need for a uniform approachPeter S. Pang, John G.F. Cleland, John R. Teerlink et al.|European Heart Journal|2008Cited by 137